1. Accueil Zonebourse
  2. Actions
  3. Royaume-Uni
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. Société
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Rapport
Temps Différé London Stock Exchange  -  27/05 17:35:46
10588.00 GBX   +0.40%
16:56ASTRAZENECA : premiers patients dans la néphrite lupique
CF
15:22AstraZeneca administre les premiers patients de l'essai de phase III évaluant l'anifrolumab dans l'inflammation rénale
MT
14:18ASTRAZENECA : Berenberg persiste à l'achat
ZD
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
Métier
Logo AstraZeneca PLC
AstraZeneca PLC figure parmi les principaux groupes pharmaceutiques mondiaux. Le CA par source de revenus se répartit comme suit :

- ventes de produits (97,7%). Le CA par domaine thérapeutique se ventile entre oncologie (35,7%), maladies cardio-vasculaires, rénales et métaboliques (21,9%), maladies respiratoires et auto-immunes (16,5%) et autres (25,9% ; maladies inflammatoires, maladies neurologiques, maladies gastro-intestinales et maladies infectieuses) ;

- revenus de collaboration (2,3%).

La répartition géographique du CA est la suivante : Royaume Uni (8,7%), Europe continentale (20,9%), Amérique (37,5%) et Afrique-Asie-Australie (32,9%).

Nombre d'employés : 83 100 personnes.
Ventes par activité
20202021Delta
Oncology8 461.0040.8%9 487.3634.9% +12.13%
Cardiovascular, Renal & Metabolism5 533.5726.7%5 831.4421.4% +5.38%
Respiratory & Immunology4 177.4720.1%4 387.3916.1% +5.03%
COVID-19--2 909.9010.7%-
Rare Disease--2 232.238.2%-
Other Medicines2 017.389.7%1 721.076.3% -14.69%
Collaboration566.932.7%636.952.3% +12.35%
GBP en Millions
Ventes par région
20202021Delta
United States6 983.2533.6%8 759.5232.2% +25.44%
China4 168.1120.1%4 364.1316% +4.7%
Japan2 001.799.6%2 468.559.1% +23.32%
United Kingdom1 357.666.5%2 359.488.7% +73.79%
Other Asia, Africa and Australasia1 196.245.8%1 729.806.4% +44.6%
Sweden800.093.9%1 688.356.2% +111.02%
Other Rest of Europe1 084.725.2%1 417.145.2% +30.65%
Germany730.693.5%1 080.494% +47.87%
Other Americas593.442.9%874.723.2% +47.4%
France509.222.5%665.312.4% +30.65%
Canada464.772.2%561.332.1% +20.78%
Spain310.371.5%420.271.5% +35.41%
Italy336.101.6%419.541.5% +24.83%
Australia219.911.1%397.731.5% +80.86%
GBP en Millions
Dirigeants
Nom Titre Age Depuis
Pascal Soriot Chief Executive Officer & Executive Director 61 2012
Aradhana Sarin Chief Financial Officer & Executive Director 47 2021
Menelas Pangalos EVP-Biopharmaceuticals Research & Development 54 2019
Pam Cheng Executive VP-Operations & Information Technology 50 2015
Henry Cremisi Medical Director - -
Katarina Ageborg Chief Compliance Officer & EVP-Sustainability - 2017
Jonathan Thomas Charles Slade Group Treasurer 56 -
Adrian Charles Noel Kemp Secretary 55 2009
Ruud Dobber, Dr. Executive VP-Biopharmaceuticals Business - 2019
Marc Dunoyer Chief Strategy Officer 69 2021
Administrateurs
Nom Titre Age Depuis
Leif Johansson Non-Executive Chairman 69 2012
Marcus Wallenberg Independent Non-Executive Director 65 1999
Philip Arthur John Broadley Senior Independent Non-Executive Director 60 2021
Nazneen Rahman, Dr. Independent Non-Executive Director - 2017
Sherilyn McCoy Independent Non-Executive Director 62 2017
Deborah DiSanzo Independent Non-Executive Director 61 2017
Tony Mok, Dr. Independent Non-Executive Director 60 2019
Michel Demaré Independent Non-Executive Director 65 2019
Pascal Soriot Chief Executive Officer & Executive Director 61 2012
Euan A. Ashley, Dr. Non-Executive Director - 2020
Actions
Vote NombreFlottantAutocontrôleFlottant Total
Action A 1 1 549 464 013 1 493 338 139 96.4% 0 0.0% 96.4%
Actionnaires
Nom Actions%
Wellington Management Co. LLP 64 146 178 4,14%
BlackRock Investment Management (UK) Ltd. 54 582 684 3,52%
Investor AB (Investment Company) 51 587 810 3,33%
The Vanguard Group, Inc. 47 828 000 3,09%
Capital Research & Management Co. (World Investors) 46 132 337 2,98%
Norges Bank Investment Management 29 629 000 1,91%
BlackRock Fund Advisors 27 435 499 1,77%
BlackRock Advisors (UK) Ltd. 21 350 923 1,38%
GQG Partners LLC 15 447 000 1,00%
SSgA Funds Management, Inc. 13 518 000 0,87%
Participations
Nom Actions%Valorisation
ASTRAZENECA PHARMA INDIA LIMITED (506820) 18 750 000 75,0% 675 483 188 USD
DIZAL JIANGSU PHARMACEUTICAL CO. LTD. 108 923 023 29,7% 342 461 609 USD
ADC THERAPEUTICS SA (ADCT) 4 011 215 5,22% 47 212 001 USD
CIRCASSIA GROUP PLC (CIR) 71 059 999 16,9% 31 582 617 USD
SILENCE THERAPEUTICS PLC (SLNCF) 4 397 247 4,90% 31 123 934 USD
INNATE PHARMA (IPH) 7 485 500 9,39% 21 637 287 USD
PIERIS PHARMACEUTICALS, INC. (PIRS) 3 584 230 4,97% 10 035 844 USD
ENTASIS THERAPEUTICS HOLDINGS INC. (ETTX) 2 164 855 4,52% 4 069 927 USD
PHASEBIO PHARMACEUTICALS, INC. (PHAS) 3 004 554 6,17% 3 635 510 USD
ARIDIS PHARMACEUTICALS, INC. (ARDS) 884 956 5,00% 1 106 195 USD
Places et indices
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, NASDAQ OMX Nordic 120, OMX Nordic 40, OMX Stockholm 30, Stoxx Europe 50, STOXX Europe 600, Stoxx Global 200, Stoxx UK 50
Codes boursiers
- Code Bloomberg :  AZN:LN
- Code Reuters :  AZN.L
- Code Datastream :  
Coordonnées société
AstraZeneca PLC
Cambridge Biomedical Campus 1 Francis Crick Avenue
CB2 0AA Cambridge, Cambridgeshire

Téléphone : +44 (0)20 3749 5000
Fax : +44 (0)20 7604 8151
Internet : https://www.astrazeneca.com/investor-relations.html
Portefeuille de Marques
En partenariat avec Mes Marques en Bourse
Plus de marques de AstraZeneca PLC
Secteur Pharmacies - Autres
Var. 1janvCapi. (M$)
ASTRAZENECA PLC21.53%205 677
JOHNSON & JOHNSON4.90%472 231
PFIZER, INC.-8.57%302 932
ROCHE HOLDING AG-12.16%282 336
ELI LILLY AND COMPANY13.48%282 164
ABBVIE INC.11.20%266 074
NOVO NORDISK A/S-4.82%242 093
MERCK & CO., INC.20.45%233 434
NOVARTIS AG4.33%198 211
BRISTOL-MYERS SQUIBB COMPANY24.44%165 194
SANOFI16.96%138 769
AMGEN INC.12.48%135 179
GLAXOSMITHKLINE PLC9.16%111 724
BAYER AG40.21%69 450
DAIICHI SANKYO CO., LTD.18.36%52 109
TAKEDA PHARMACEUTICAL COMPANY LIMITED19.92%45 598
CHUGAI PHARMACEUTICAL CO., LTD-7.76%44 487
ASTELLAS PHARMA INC.8.85%28 794
JIANGSU HENGRUI MEDICINE CO., LTD.-41.27%27 490
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD-32.43%26 437
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY-15.93%20 825